These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 37028431)

  • 1. Cognitive heterogeneity in Parkinson's disease: A mechanistic view.
    Carceles-Cordon M; Weintraub D; Chen-Plotkin AS
    Neuron; 2023 May; 111(10):1531-1546. PubMed ID: 37028431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α-Synuclein pathology in Parkinson's disease and related α-synucleinopathies.
    Henderson MX; Trojanowski JQ; Lee VM
    Neurosci Lett; 2019 Sep; 709():134316. PubMed ID: 31170426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies.
    Brás IC; Outeiro TF
    Cells; 2021 Feb; 10(2):. PubMed ID: 33673034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do Lewy bodies contain alpha-synuclein fibrils? and Does it matter? A brief history and critical analysis of recent reports.
    Lashuel HA
    Neurobiol Dis; 2020 Jul; 141():104876. PubMed ID: 32339655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prominent astrocytic alpha-synuclein pathology with unique post-translational modification signatures unveiled across Lewy body disorders.
    Altay MF; Liu AKL; Holton JL; Parkkinen L; Lashuel HA
    Acta Neuropathol Commun; 2022 Nov; 10(1):163. PubMed ID: 36371251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ⍺-Synuclein Structural Diversity and the Cellular Environment in ⍺-Synuclein Transmission Models and Humans.
    Peelaerts W; Baekelandt V
    Neurotherapeutics; 2023 Jan; 20(1):67-82. PubMed ID: 37052776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders.
    Jellinger KA
    Biochim Biophys Acta; 2009 Jul; 1792(7):730-40. PubMed ID: 18718530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic rodent models to study alpha-synuclein pathogenesis, with a focus on cognitive deficits.
    Hatami A; Chesselet MF
    Curr Top Behav Neurosci; 2015; 22():303-30. PubMed ID: 25218491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroinflammation and protein pathology in Parkinson's disease dementia.
    Kouli A; Camacho M; Allinson K; Williams-Gray CH
    Acta Neuropathol Commun; 2020 Dec; 8(1):211. PubMed ID: 33272323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The subcellular arrangement of alpha-synuclein proteoforms in the Parkinson's disease brain as revealed by multicolor STED microscopy.
    Moors TE; Maat CA; Niedieker D; Mona D; Petersen D; Timmermans-Huisman E; Kole J; El-Mashtoly SF; Spycher L; Zago W; Barbour R; Mundigl O; Kaluza K; Huber S; Hug MN; Kremer T; Ritter M; Dziadek S; Geurts JJG; Gerwert K; Britschgi M; van de Berg WDJ
    Acta Neuropathol; 2021 Sep; 142(3):423-448. PubMed ID: 34115198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable expression of mitochondrial complex IV in the course of nigral intracellular accumulation of α-synuclein.
    Lang A; Dassler E; Milenkovic I; Lutz MI; Kovacs GG
    Parkinsonism Relat Disord; 2021 Sep; 90():57-61. PubMed ID: 34385008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein trapping leads to altered synaptic proteostasis in synucleinopathies.
    Santos PI; Outeiro TF
    FEBS J; 2020 Dec; 287(24):5294-5303. PubMed ID: 32400966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ɑ-Synuclein strains and seeding in Parkinson's disease, incidental Lewy body disease, dementia with Lewy bodies and multiple system atrophy: similarities and differences.
    Peelaerts W; Bousset L; Baekelandt V; Melki R
    Cell Tissue Res; 2018 Jul; 373(1):195-212. PubMed ID: 29704213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy.
    Earls RH; Menees KB; Chung J; Gutekunst CA; Lee HJ; Hazim MG; Rada B; Wood LB; Lee JK
    Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1762-1771. PubMed ID: 31900358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson's disease.
    Price DL; Koike MA; Khan A; Wrasidlo W; Rockenstein E; Masliah E; Bonhaus D
    Sci Rep; 2018 Nov; 8(1):16165. PubMed ID: 30385782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats.
    Van Den Berge N; Ferreira N; Gram H; Mikkelsen TW; Alstrup AKO; Casadei N; Tsung-Pin P; Riess O; Nyengaard JR; Tamgüney G; Jensen PH; Borghammer P
    Acta Neuropathol; 2019 Oct; 138(4):535-550. PubMed ID: 31254094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
    Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
    Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-synuclein pathology, microgliosis, and parvalbumin neuron loss in the amygdala associated with enhanced fear in the Thy1-aSyn model of Parkinson's disease.
    Torres ERS; Stanojlovic M; Zelikowsky M; Bonsberger J; Hean S; Mulligan C; Baldauf L; Fleming S; Masliah E; Chesselet MF; Fanselow MS; Richter F
    Neurobiol Dis; 2021 Oct; 158():105478. PubMed ID: 34390837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
    Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
    J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α-Synuclein Conformations in Plasma Distinguish Parkinson's Disease from Dementia with Lewy Bodies.
    Kannarkat GT; Zack R; Skrinak RT; Morley JF; Davila-Rivera R; Arezoumandan S; Dorfmann K; Luk K; Wolk DA; Weintraub D; Tropea TF; Lee EB; Xie SX; Chandrasekaran G; Lee VM; Irwin D; Akhtar RS; Chen-Plotkin AS
    bioRxiv; 2024 May; ():. PubMed ID: 38765963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.